Search for Clinical Trial Results
Carcinoma in Situ - 37 Studies Found
Status | Study |
Not yet recruiting |
Study Name: Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ Condition: Ductal Carcinoma In Situ Date: 2016-08-30 Interventions: Procedure: Sentinel lymph node biopsy (SLNB) Intervention is defined as that the DCIS patient has underg |
Completed |
Study Name: A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ Condition: Ductal Carcinoma in Situ Date: 2012-06-20 Interventions: Dietary Supplement: Black cohosh Remifemin 20 mg tablet orally twice per day x 4 weeks |
Completed |
Study Name: Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ (DCIS) Condition: Ductal Carcinoma In Situ Date: 2008-04-28 Interventions:
|
Completed |
Study Name: Neoadjuvant Herceptin for Ductal Carcinoma In Situ of the Breast Condition: Ductal Carcinoma In Situ Date: 2007-07-03 Interventions: Drug: Herceptin (Trastuzumab) 8 mg/kg IV Over 90 Minutes |
Terminated |
Study Name: Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast Condition: Ductal Carcinoma in Situ Date: 2009-03-06 Interventions: Drug: lapatinib 1500 mg lapatinib for 14-21 days Oth |
Terminated |
Study Name: A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ Condition: Ductal Carcinoma in Situ Date: 2010-01-29 Interventions: Drug: Polyphenon E three 200mg capsules (600mg total dose of the study drug) with food (within one hour |
Completed |
Study Name: Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer Condition:
Date: 2012-11-12 Interventions: Drug: TMX-101 Other Name: Imiquimod |
Completed |
Study Name: Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) Condition:
Date: 2011-03-15 Interventions: Drug: Valrubicin, 800 mg Investigator will be responsible for regulating the use of concomitant medicati |
Completed |
Study Name: Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast Condition: Intraductal Carcinoma and Lobular Carcinoma in Situ Date: 2012-11-05 Interventions: Procedure: sentinel node biopsy and mastectomy sentinel node biopsy and mastectomy |
Recruiting |
Study Name: MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ Condition: Ductal Breast Carcinoma In Situ Date: 2015-01-16 Interventions:
|